Opinion

Video

Biomarkers as Tools in Management of Type 2 Inflammation

An expert in COPD delves into biomarkers indicative of type 2 inflammation and recommends diagnostic tests for assessing inflammation in COPD patients.

  • What biomarkers can reliably assess the presence of type 2 inflammation as a contributing factor in asthma or COPD?
  • How can absolute eosinophil count specifically be used as a tool in this population for regimen selection? Does this biomarker have a role in predicting treatment response or patient outcomes?
Related Videos
1 expert is featured in this series.
1 expert is featured in this series.
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo